TXG - 10x Genomics, Inc.

20.81
-0.830   -3.988%

Share volume: 1,615,651
Last Updated: 03-06-2026
Measuring And Control Equipment/Lab Analytical Instruments: -0.08%

PREVIOUS CLOSE
CHG
CHG%
$21.64
-0.83
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
40%
Profitability 35%
Dept financing 23%
Liquidity 75%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-10.07%
1 Month
12.24%
3 Months
19.12%
6 Months
49.39%
1 Year
77.86%
2 Year
78.63%
Key data
Stock price
$20.81
P/E Ratio 
0.00
DAY RANGE
$20.57 - $21.43
EPS 
-$1.03
52 WEEK RANGE
$6.78 - $23.56
52 WEEK CHANGE
$96.51
MARKET CAP 
2.064 B
YIELD 
N/A
SHARES OUTSTANDING 
127.752 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-07-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$2,608,228
AVERAGE 30 VOLUME 
$2,826,238
Company detail
CEO: Serge Saxonov
Region: US
Website: 10xgenomics.com
Employees: 1,240
IPO year: 2019
Issue type:
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression.

Recent news